nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

11.09.2023 | Rhinology

The first quick olfactory test specific for Alzheimer’s disease and French culture

verfasst von: Anais Feing-Kwong-Chan, Valeria Manera, Magali Payne, Alexandre Derreumaux, Justine Lemaire, Guillaume Sacco, Aurélie Mouton, Alexandra Plonka, Xavier Fernandez, Clair Vandersteen, Auriane Gros

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Olfactory identification disorder is considered a promising early biomarker of Alzheimer's disease (AD). The QUICK TODA2 can be used as a short olfactory screening tool specific for French AD patients. The selection of AD specific odorants and the design of this screening were the main objectives of this twofold study.

Methods

In study 1, the TODA2 olfactory test was administered to 43 mild-AD patients and 45 healthy controls (HC) in five memory centres in France. The selection of AD specific odorants was based on the differences in the proportion of correct answers and in the threshold means between AD and HC groups. In study 2, another set of 19 mild-AD patient were included at the memory centre of Nice Hospital. All participants completed the olfactory assessment pipeline including the QUICK TODA2, TODA2 and Sniffin’ Sticks Identification sub-Test (SST-i). The individual scores of the three tests were correlated.

Results

In study 1, ten TODA2 odorants could significantly differentiate AD participants from controls. We selected the six most AD-sensitive items to design the QUICK TODA2. In study 2, we reported strong significant correlations between QUICK TODA2 and TODA2 (ρ₍₁₇₎ = 0.68, p = 0.001**), SST-i and QUICK TODA2 (ρ₍₁₇₎ = 0.65, p = 0.002**), SST-i and TODA2 (ρ₍₁₇₎ = 0.57, p = 0.01*).

Conclusion

QUICK TODA2 is a 5-min non-invasive olfactory AD screening tool dedicated to French culture. Its results converge with those of longer, validated olfactory tests. It could be used as a quick screening tool in the general daily practice before an extensive assessment in memory centres.

Demarquay G, Ryvlin P, Royet JP (2007) Olfaction et pathologies neurologiques: revue de la littérature. Revue Neurolog 163:155–167. https://doi.org/10.1016/S0035-3787(07)90387-2CrossRef

Serby M, Larson P, Kalkstein D (1991) The nature and course of olfactory deficits in Alzheimer’s disease. AJP 148:357–360. https://doi.org/10.1176/ajp.148.3.357CrossRef

Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. AJP 157:1399–1405. https://doi.org/10.1176/appi.ajp.157.9.1399CrossRef

Naudin M, Mondon K, Atanasova B (2013) Alzheimer’s disease and olfaction. Gériatrie et Psychologie Neuropsychiatrie du Viellissement 11:287–293. https://doi.org/10.1684/pnv.2013.0418CrossRef

Hedner M, Larsson M, Arnold N, Zucco GM, Hummel T (2010) Cognitive factors in odor detection, odor discrimination, and odor identification tasks. J Clin Exp Neuropsychol 32:1062–1067. https://doi.org/10.1080/13803391003683070CrossRefPubMed

Rahayel S, Frasnelli J, Joubert S (2012) The effect of Alzheimer’s disease and Parkinson’s disease on olfaction: a meta-analysis. Behav Brain Res 231:60–74. https://doi.org/10.1016/j.bbr.2012.02.047CrossRefPubMed

Lafaille-Magnan M-E, Poirier J, Etienne P, Tremblay-Mercier J, Frenette J, Rosa-Neto P, Breitner JCS, For the PREVENT-AD Research Group (2017) Odor identification as a biomarker of preclinical AD in older adults at risk. Neurology 89:327–335. https://doi.org/10.1212/WNL.0000000000004159CrossRefPubMedPubMedCentral

Ottaviano G, Frasson G, Nardello E, Martini A (2016) Olfaction deterioration in cognitive disorders in the elderly. Aging Clin Exp Res 28:37–45. https://doi.org/10.1007/s40520-015-0380-xCrossRefPubMed

Sun GH, Raji CA, MacEachern MP, Burke JF (2012) Olfactory identification testing as a predictor of the development of Alzheimer’s dementia: A systematic review. Laryngoscope 122:1455–1462. https://doi.org/10.1002/lary.23365CrossRefPubMed

10.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia 7:263–269. https://doi.org/10.1016/j.jalz.2011.03.005CrossRef

11.

Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, Damm M, Frasnelli J, Gudziol H, Gupta N, Haehne A, Holbrook E, Hong SC, Hornung D, Huttenbrink KB, Kamel R, Kobayashi M, Konstantinidis I, Landis BN, Leopold DA, Macchi A, Miwa T, Moesges R, Mullol J, Mueller CA, Ottaviano G, Passali GC, Philpott C, Pinto JM, Ramakrishnan VJ, Rombaux P, Roth Y, Schlosser RA, Shu B, Soler G, Stjarne P, Stuck BA, Vodicka J, Welge-Luessen A (2017) Position paper on olfactory dysfunction. Rhin 54:1–30. https://doi.org/10.4193/Rhino16.248CrossRef

12.

Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G (1997) “Sniffin” Sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22:39–52. https://doi.org/10.1093/chemse/22.1.39CrossRefPubMed

13.

Doty RL (2007) Office procedures for quantitative assessment of olfactory function. Am J Rhinol 21:460–473. https://doi.org/10.2500/ajr.2007.21.3043CrossRefPubMed

14.

Gros A, Manera V, De March CA, Guevara N, König A, Friedman L, Robert P, Golebiowski J, David R (2017) Olfactory disturbances in ageing with and without dementia: towards new diagnostic tools. J Laryngol Otol 131:572–579. https://doi.org/10.1017/S0022215117000858CrossRefPubMed

15.

Nordin S, Monsch AU, Murphy C (1995) Unawareness of smell loss in normal aging and Alzheimer’s disease: discrepancy between self-reported and diagnosed smell sensitivity. J Gerontol B Psychol Sci Soc Sci 50B:P187–P192. https://doi.org/10.1093/geronb/50B.4.P187CrossRef

16.

Tahmasebi R, Zehetmayer S, Stögmann E, Lehrner J (2020) Awareness of olfactory dysfunction in subjective cognitive decline, mild cognitive decline, and Alzheimer’s disease. Chem Percept 13:59–70. https://doi.org/10.1007/s12078-019-09267-7CrossRef

17.

Doty RL, Reyes PF, Gregor T (1987) Presence of both odor identification and detection deficits in Alzheimer’s disease. Brain Res Bull 18:597–600. https://doi.org/10.1016/0361-9230(87)90129-8CrossRefPubMed

18.

Payne M, Manera V, Robert P, Vandersteen C, Beauchet O, Galery K, Sacco G, Fabre R, Gros A (2022) Olfactory identification disorders due to Alzheimer’s disease: a new test from France to Quebec. PLoS ONE 17:e0265764. https://doi.org/10.1371/journal.pone.0265764CrossRefPubMedPubMedCentral

19.

American Psychiatric Association (2022) DSM-5: diagnostic and statistical manual of mental disorders, 5th edition, Text revision (DSM-5-TR®)

20.

Organisation Mondiale de la Santé (1994) CIM-10 Classification Internationale des Maladies et des Troubles Mentaux et troubles du Comportement, Critères Diagnostiques pour la Recherche, Elsevier Masson

21.

Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. J Psychiatr Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6CrossRefPubMed

22.

Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP (2005) A 10-item smell identification scale related to risk for Alzheimer’s disease. Ann Neurol 58:155–160. https://doi.org/10.1002/ana.20533CrossRefPubMed

23.

Woodward MR, Amrutkar CV, Shah HC, Benedict RHB, Rajakrishnan S, Doody RS, Yan L, Szigeti K (2017) Validation of olfactory deficit as a biomarker of Alzheimer disease. Neurol Clin Pract 7:5–14. https://doi.org/10.1212/CPJ.0000000000000293CrossRefPubMedPubMedCentral

24.

Woodward MR, Hafeez MU, Qi Q, Riaz A, Benedict RHB, Yan L, Szigeti K, Pavlik V, Massman P, Darby E, Rodriguear M, Khaleeq Ansari A, DeToledo JC, Reddy H, Wilms H, Johnson K, Perez V, Fairchild T, Knebl J, O’Bryant SE, Hall JR, Johnson L, Barber RC, Mains D, Alvarez L, Cullum M, Rosenberg R, Williams B, Quiceno M, Reisch J, Hynan LS, Huebinger R, Smith J, Nguyen T, Royall D, Palmer R, Polk M, Stevens A, Ory M, Paydarfar D, Bertelson J, Woon M, Ayres G, Aguirre A, Wilhelmsen KC, Tilson JL (2018) Odorant item specific olfactory identification deficit may differentiate Alzheimer disease from aging. Am J Geriatr Psychiatry 26:835–846. https://doi.org/10.1016/j.jagp.2018.02.008CrossRefPubMedPubMedCentral

25.

Jimbo D, Inoue M, Taniguchi M, Urakami K (2011) Specific feature of olfactory dysfunction with Alzheimer’s disease inspected by the odor stick identification test: olfactory loss for diagnosing AD. Psychogeriatrics 11:196–204. https://doi.org/10.1111/j.1479-8301.2011.00387.xCrossRefPubMed

26.

Zendehbad AS, Noroozian M, Shakiba A, Kargar A, Davoudkhani M (2022) Validation of Iranian Smell Identification Test for screening of mild cognitive impairment and Alzheimer’s disease. Appl Neuropsychol Adult 29:77–82. https://doi.org/10.1080/23279095.2019.1710508CrossRefPubMed

27.

Doty RL, Shaman P, Dann M (1984) Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function. Physiol Behav 32:489–502. https://doi.org/10.1016/0031-9384(84)90269-5CrossRefPubMed

28.

Stamps JJ, Bartoshuk LM, Heilman KM (2013) A brief olfactory test for Alzheimer’s disease. J Neurol Sci 333:19–24. https://doi.org/10.1016/j.jns.2013.06.033CrossRefPubMed

29.

Doty RL, Bayona EA, Leon-Ariza DS, Cuadros J, Chung I, Vazquez B, Leon-Sarmiento FE (2014) The lateralized smell test for detecting Alzheimer’s disease: failure to replicate. J Neurol Sci 340:170–173. https://doi.org/10.1016/j.jns.2014.03.022CrossRefPubMedPubMedCentral

30.

Kjelvik G, Sando SB, Aasly J, Engedal KA, White LR (2007) Use of the Brief Smell Identification Test for olfactory deficit in a Norwegian population with Alzheimer’s disease. Int J Geriat Psychiatry 22:1020–1024. https://doi.org/10.1002/gps.1783CrossRef

31.

Albrecht T, Beule AG, Hildenbrand T, Gerstacker K, Praetorius M, Rudack C, Baumann I (2022) Cross-cultural adaptation and validation of the 22-item sinonasal outcome test (SNOT-22) in German-speaking patients: a prospective, multicenter cohort study. Eur Arch Otorhinolaryngol 279:2433–2439. https://doi.org/10.1007/s00405-021-07019-6CrossRefPubMed

32.

Yoshitake M, Maeshima E, Maeshima S, Osawa A, Ito N, Ueda I, Kamiya M (2022) Olfactory identification ability in patients with mild cognitive impairment and Alzheimer’s disease. J Phys Ther Sci 34:710–714. https://doi.org/10.1589/jpts.34.710CrossRefPubMedPubMedCentral

33.

Silveira-Moriyama L, Azevedo AMS, Ranvaud R, Barbosa ER, Doty RL, Lees AJ (2010) Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil. Arq Neuro-Psiquiatr 68:700–705. https://doi.org/10.1590/S0004-282X2010000500005CrossRef

34.

Jiang R-S, Su M-C, Liang K-L, Shiao J-Y, Wu S-H, Hsin C-H (2010) A pilot study of a traditional Chinese version of the University of Pennsylvania Smell Identification Test for application in Taiwan. Am J RhinoloAllergy 24:45–50. https://doi.org/10.2500/ajra.2010.24.3388CrossRef

35.

Chrea C, Valentin D, Abdi H (2009) Graded structure in odour categories: a cross-cultural case study. Perception 38:292–309. https://doi.org/10.1068/p5687CrossRefPubMed

36.

Chrea C, Valentin D, Sulmont-Rossé C, Ly Mai H, Hoang Nguyen D, Abdi H (2004) Culture and odor categorization: agreement between cultures depends upon the odors. Food Qual Prefer 15:669–679. https://doi.org/10.1016/j.foodqual.2003.10.005CrossRef

37.

Hummel T, Pfetzing U, Lötsch J (2010) A short olfactory test based on the identification of three odors. J Neurol 257:1316–1321. https://doi.org/10.1007/s00415-010-5516-5CrossRefPubMed

38.

Sorokowska A, Oleszkiewicz A, Minovi A, Konnerth CG, Hummel T (2019) Fast screening of olfactory function using the Q-sticks test. ORL 81:245–251. https://doi.org/10.1159/000500559CrossRefPubMed

39.

Hummel T, Rosenheim K, Konnerth C-G, Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110:976–981. https://doi.org/10.1177/000348940111001015CrossRefPubMed

40.

Hüttenbrink K-B, Hummel T, Berg D, Gasser T, Hähner A (2013) Olfactory dysfunction. Dtsch Arztebl Int. https://doi.org/10.3238/arztebl.2013.0001CrossRefPubMedPubMedCentral

Titel: The first quick olfactory test specific for Alzheimer’s disease and French culture
verfasst von: Anais Feing-Kwong-Chan
Valeria Manera
Magali Payne
Alexandre Derreumaux
Justine Lemaire
Guillaume Sacco
Aurélie Mouton
Alexandra Plonka
Xavier Fernandez
Clair Vandersteen
Auriane Gros
Publikationsdatum: 11.09.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 2/2024
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-023-08217-0

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The first quick olfactory test specific for Alzheimer’s disease and French culture